ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
36
views
0
references
Top references
cited by
6
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,270
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Phase III Trial of Cetuximab, Bevacizumab, and 5-Fluorouracil/Leucovorin vs. FOLFOX-Bevacizumab in Colorectal Cancer
Author(s):
Leonard Saltz
,
Suprith Badarinath
,
Shaker Dakhil
,
Bryan Bienvenu
,
W Harker
,
George Birchfield
,
Laurence K Tokaz
,
David Barrera
,
Paul Conkling
,
Mark O'Rourke
,
Donald Richards
,
Diane Reidy
,
David B Solit
,
Efsevia Vakiani
,
Marinella Capanu
,
Amy Scales
,
Feng Zhan
,
Kristi Boehm
,
Lina Asmar
,
Allen Lee Cohn
Publication date:
2012-06-01
Journal:
Clinical colorectal cancer
Publisher:
Elsevier BV
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Model Reduction of Parametrized Systems 2015
Author and article information
Journal
DOI::
10.1016/j.clcc.2011.05.006
PubMed ID::
22055112
License:
https://www.elsevier.com/tdm/userlicense/1.0/
Data availability:
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,270
Adjuvant chemotherapy with oxaliplatin/5-fluorouracil/leucovorin (FOLFOX) versus 5-fluorouracil/leucovorin (FL) for rectal cancer patients whose postoperative yp stage 2 or 3 after preoperative chemoradiotherapy: Updated results of 3-year disease-free survival from a randomized phase II study (The ADORE) [Abstract]
Authors:
YS Hong
,
B Nam
,
K Kim
…
Overview of the Efficacy of Cetuximab in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck in Patients Who Previously Failed Platinum-Based Therapies
Authors:
JB Vermorken
,
RS Herbst
,
X Leon
Phase I trial of preoperative cetuximab with concurrent continuous infusion 5-fluorouracil and pelvic radiation in patients with local-regionally advanced rectal cancer
Authors:
KY Chung
,
B Minsky
,
D Schrag
See all similar
Cited by
19
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Authors:
Theo Ruers
,
Frits Van Coevorden
,
Cornelis Punt
…
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial
Authors:
T. Gruenberger
,
J. Bridgewater
,
I. Chau
…
Beyond second-line therapy in patients with metastatic colorectal cancer: a systematic review
Authors:
D. Arnold
,
G W Prager
,
A. Quintela
…
See all cited by
Version 1
- Current
Version 1